Toru Iwaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Toru Iwaki has a total of 299 co-authors. Here are the top co-authors by number of shared publications:
Satoshi O. Suzuki
Department of Neuropathology, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
24 shared publications- Hiroyuki Honda
Neuropathology Center, National Hospital Organization, Omuta Hospital , Omuta
21 shared publications - Nobuhiro Hata
Department of Neurosurgery, Oita University Faculty of Medicine, Yufu, Japan
14 shared publications - Hideomi Hamasaki
Department of Neuropathology Graduate School of Medical Sciences Kyushu University Fukuoka Japan
12 shared publications - Jun-Ichi Kira
Department of Neurology, Brain and Nerve Center Fukuoka Central Hospital Fukuoka Japan
11 shared publications - Ryo Yamasaki
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
11 shared publications
Latest Publications
- Open Access
- 6 February 2023
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2023, 1
Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer’s Disease”
[This corrects the article DOI: 10.1155/2021/8635088.].
- 6 February 2023
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2023, 1
Open AccessCorrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer’s Disease”
[This corrects the article DOI: 10.1155/2021/8635088.].
- Open Access
- 11 November 2022
- Published by Wiley in Brain Pathology
- Vol. 33 (3)
Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy
The pathological hallmark of multiple system atrophy (MSA) is aberrant accumulation of phosphorylated α‐synuclein in oligodendrocytes, forming glial cytoplasmic inclusions (GCIs). Extensive demyelination occurs particularly in the olivopontocerebellar and striatonigral pathways, but its precise mechanism remains elusive. Glial connexins (Cxs), which form gap junction channels between astrocytes and oligodendrocytes, play critical roles in myelin maintenance, and have not been studied in MSA. Therefore, we immunohistochemically investigated glial Cx changes in the cerebellar afferent fibers in 15 autopsied patients with MSA. We classified demyelinating lesions into three stages based on Klüver–Barrera staining: early (Stage I), intermediate (Stage II), and late (Stage III) stages showing subtle, moderate, and severe myelin reduction, respectively. Myelin‐associated glycoprotein, but not myelin oligodendrocyte glycoprotein, was preferentially decreased in Stage I, suggesting distal oligodendrogliopathy type demyelination. Accumulation of phosphorylated α‐synuclein in oligodendrocytes was frequently seen in Stage I but less frequently observed in Stages II and III. Tubulin polymerization‐promoting protein (TPPP/p25α)‐positive oligodendrocytes were preserved in Stage I but successively decreased in Stages II and III. Even at Stage I, Cx32 was nearly absent from myelin, despite the relative preservation of other nodal proteins, such as neurofascin, claudin‐11/oligodendrocyte‐specific protein, and contactin‐associated protein 1, which successively decreased in the later stages. Cx32 was re‐distributed in the oligodendrocyte cytoplasm and co‐localized with GCIs. Cx47 gradually decreased at the oligodendrocyte surface in a stage‐dependent manner but was not co‐localized with GCIs. Astrocytic Cx43 was down‐regulated in Stage I but up‐regulated in Stages II and III, reflecting astrogliosis. Cx43/Cx47 gap junctions significantly decreased from Stage I to III. Activated microglia/macrophages and T cells infiltrated in Stage I rather than Stages II and III. Therefore, early and extensive alterations of glial Cxs, particularly Cx32 loss, occur in MSA and may accelerate distal oligodendrogliopathy type demyelination and nodal/paranodal dysfunction through disruption of inter‐glial communication.
- 11 November 2022
- Published by Wiley in Brain Pathology
- Vol. 33 (3)
Open AccessEarly and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy
The pathological hallmark of multiple system atrophy (MSA) is aberrant accumulation of phosphorylated α‐synuclein in oligodendrocytes, forming glial cytoplasmic inclusions (GCIs). Extensive demyelination occurs particularly in the olivopontocerebellar and striatonigral pathways, but its precise mechanism remains elusive. Glial connexins (Cxs), which form gap junction channels between astrocytes and oligodendrocytes, play critical roles in myelin maintenance, and have not been studied in MSA. Therefore, we immunohistochemically investigated glial Cx changes in the cerebellar afferent fibers in 15 autopsied patients with MSA. We classified demyelinating lesions into three stages based on Klüver–Barrera staining: early (Stage I), intermediate (Stage II), and late (Stage III) stages showing subtle, moderate, and severe myelin reduction, respectively. Myelin‐associated glycoprotein, but not myelin oligodendrocyte glycoprotein, was preferentially decreased in Stage I, suggesting distal oligodendrogliopathy type demyelination. Accumulation of phosphorylated α‐synuclein in oligodendrocytes was frequently seen in Stage I but less frequently observed in Stages II and III. Tubulin polymerization‐promoting protein (TPPP/p25α)‐positive oligodendrocytes were preserved in Stage I but successively decreased in Stages II and III. Even at Stage I, Cx32 was nearly absent from myelin, despite the relative preservation of other nodal proteins, such as neurofascin, claudin‐11/oligodendrocyte‐specific protein, and contactin‐associated protein 1, which successively decreased in the later stages. Cx32 was re‐distributed in the oligodendrocyte cytoplasm and co‐localized with GCIs. Cx47 gradually decreased at the oligodendrocyte surface in a stage‐dependent manner but was not co‐localized with GCIs. Astrocytic Cx43 was down‐regulated in Stage I but up‐regulated in Stages II and III, reflecting astrogliosis. Cx43/Cx47 gap junctions significantly decreased from Stage I to III. Activated microglia/macrophages and T cells infiltrated in Stage I rather than Stages II and III. Therefore, early and extensive alterations of glial Cxs, particularly Cx32 loss, occur in MSA and may accelerate distal oligodendrogliopathy type demyelination and nodal/paranodal dysfunction through disruption of inter‐glial communication.
- 1 March 2022
- Published by Elsevier in World Neurosurgery
- Vol. 159, e479-e487
Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study
- 1 March 2022
- Published by Elsevier in World Neurosurgery
- Vol. 159, e479-e487
Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study
- 20 February 2022
- Published by Wiley in Neuropathology
- Vol. 42 (3) , 197-203
A case of ganglioglioma grade 3 withH3 K27Mmutation arising in the medial temporal lobe in an elderly patient
The mutation p.K27M inH3F3A(H3K27M mutation) is mainly detected in diffuse midline glioma. However, recent studies have demonstrated thatH3K27M mutation could also be observed in a subset of gangliogliomas. Importantly, mostH3K27‐mutated ganglioglioma cases also harborBRAFV600E mutation. Herein, we report a rare case ofH3K27M‐mutated ganglioglioma grade 3 withoutBRAFmutation arising in the medial temporal lobe in an elderly man. A small biopsy specimen was sampled. The pathological diagnosis was diffuse astrocytoma. The tumor progressed gradually during an 18‐month follow‐up period. Gadolinium enhancement on magnetic resonance imaging was noted 36 months after the biopsy. The patient was referred to a hospital for tumor resection. Histological analysis of resected specimens led to a diagnosis of ganglioglioma grade 3 with H3 K27M mutation. The patient underwent concurrent temozolomide chemotherapy with radiotherapy. Although the patient's condition deteriorated after chemotherapy due to disease progression, he survived for more than 23 months after tumor resection. We present this rare case and discuss the involvement ofH3K27M mutation in ganglioglioma grade 3.
- 20 February 2022
- Published by Wiley in Neuropathology
- Vol. 42 (3) , 197-203
A case of ganglioglioma grade 3 withH3 K27Mmutation arising in the medial temporal lobe in an elderly patient
The mutation p.K27M inH3F3A(H3K27M mutation) is mainly detected in diffuse midline glioma. However, recent studies have demonstrated thatH3K27M mutation could also be observed in a subset of gangliogliomas. Importantly, mostH3K27‐mutated ganglioglioma cases also harborBRAFV600E mutation. Herein, we report a rare case ofH3K27M‐mutated ganglioglioma grade 3 withoutBRAFmutation arising in the medial temporal lobe in an elderly man. A small biopsy specimen was sampled. The pathological diagnosis was diffuse astrocytoma. The tumor progressed gradually during an 18‐month follow‐up period. Gadolinium enhancement on magnetic resonance imaging was noted 36 months after the biopsy. The patient was referred to a hospital for tumor resection. Histological analysis of resected specimens led to a diagnosis of ganglioglioma grade 3 with H3 K27M mutation. The patient underwent concurrent temozolomide chemotherapy with radiotherapy. Although the patient's condition deteriorated after chemotherapy due to disease progression, he survived for more than 23 months after tumor resection. We present this rare case and discuss the involvement ofH3K27M mutation in ganglioglioma grade 3.
- 1 October 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 209, 106922
Acute-phase electroencephalography for an infantile atypical teratoid/rhabdoid tumor
- 1 October 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 209, 106922
Acute-phase electroencephalography for an infantile atypical teratoid/rhabdoid tumor
- Open Access
- 9 September 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-2
Author Correction: Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
- 9 September 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-2
Open AccessAuthor Correction: Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
- Open Access
- 13 August 2021
- Published by Wiley in Brain Pathology
- Vol. 32 (1) , e13014
Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: The Hisayama study
Previous studies have revealed risk for cognitive impairment in cardiovascular diseases. We investigated the relationship between degenerative changes of the brain and heart, with reference to Alzheimer's disease (AD) pathologies, cardiac transthyretin amyloid (ATTR) deposition, and cardiac fibrosis. A total of 240 consecutive autopsy cases of a Japanese population‐based study were examined. β amyloid (Aβ) of senile plaques, phosphorylated tau protein of neurofibrillary tangles, and ATTR in the hearts were immunohistochemically detected and graded according to the NIH‐AA guideline for AD pathology and as Tanskanen reported, respectively. Cerebral amyloid angiopathy (CAA) was graded according to the Vonsattel scale. Cardiac fibrosis was detected by picrosirius red staining, followed by image analysis. Cardiac ATTR deposition occurred after age 75 years and increased in an age‐dependent manner. ATTR deposition was more common, and of higher grades, in the dementia cases. We subdivided the cases into two age groups: ≤90 years old (n = 173) and >90 years old (n = 67), which was the mean and median age at death of the AD cases. When adjusted for age and sex, TTR deposition grades correlated with Aβ phase score (A2–3), the Consortium to Establish a Registry for AD score (sparse to frequent), and high Braak stage (V–VI) only in those aged ≤90 years at death. No significant correlation was observed between the cardiac ATTR deposition and CAA stages, or between cardiac fibrosis and AD pathologies. Collectively, AD brain pathology correlated with cardiac TTR deposition among the older adults ≤90 years.
- 13 August 2021
- Published by Wiley in Brain Pathology
- Vol. 32 (1) , e13014
Open AccessConcurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: The Hisayama study
Previous studies have revealed risk for cognitive impairment in cardiovascular diseases. We investigated the relationship between degenerative changes of the brain and heart, with reference to Alzheimer's disease (AD) pathologies, cardiac transthyretin amyloid (ATTR) deposition, and cardiac fibrosis. A total of 240 consecutive autopsy cases of a Japanese population‐based study were examined. β amyloid (Aβ) of senile plaques, phosphorylated tau protein of neurofibrillary tangles, and ATTR in the hearts were immunohistochemically detected and graded according to the NIH‐AA guideline for AD pathology and as Tanskanen reported, respectively. Cerebral amyloid angiopathy (CAA) was graded according to the Vonsattel scale. Cardiac fibrosis was detected by picrosirius red staining, followed by image analysis. Cardiac ATTR deposition occurred after age 75 years and increased in an age‐dependent manner. ATTR deposition was more common, and of higher grades, in the dementia cases. We subdivided the cases into two age groups: ≤90 years old (n = 173) and >90 years old (n = 67), which was the mean and median age at death of the AD cases. When adjusted for age and sex, TTR deposition grades correlated with Aβ phase score (A2–3), the Consortium to Establish a Registry for AD score (sparse to frequent), and high Braak stage (V–VI) only in those aged ≤90 years at death. No significant correlation was observed between the cardiac ATTR deposition and CAA stages, or between cardiac fibrosis and AD pathologies. Collectively, AD brain pathology correlated with cardiac TTR deposition among the older adults ≤90 years.
- 12 August 2021
- Published by Wiley in Neuropathology
- Vol. 41 (5) , 381-386
Intraventricular mucin‐producing glioblastoma arising in the septum pellucidum at the frontal horn of the lateral ventricle: A case report
Glioblastoma (GBM) most commonly appears to be intraparenchymal tumor, and intraventricular GBMs are rarely reported. In previous reports, the sites of origin were not identified. Here, we report a rare case of intraventricular mucin-producing GBM in a 73-year-old woman who had a strongly enhancing tumor in the right anterior horn of the lateral ventricle. The tumor had previously been identified one and a half years ago as a small asymptomatic lesion attached to the septum pellucidum. It had been documented to gradually enlarge during subsequent follow-up examinations. The patient underwent a gross total resection of the tumor, and a soft and gelatinous mass was observed. The pathological diagnosis was compatible with GBM, and numerous tumor cells having cytoplasmic mucin vacuoles were observed. Genetic analysis revealed TP53 and NFKBIA deletions. The patient received postoperative concurrent chemotherapy with temozolomide and radiotherapy, followed by maintenance administration of temozolomide. A follow-up examination seven months later detected an asymptomatic local recurrent lesion, which was treated with gamma-knife therapy, followed by bevacizumab administration for six months. The patient has remained clinically well for five years following surgery. The origin of a rare tumor entity, intraventricular GBM, and the specific spatial and pathological findings in our case are discussed in this report.
- 12 August 2021
- Published by Wiley in Neuropathology
- Vol. 41 (5) , 381-386
Intraventricular mucin‐producing glioblastoma arising in the septum pellucidum at the frontal horn of the lateral ventricle: A case report
Glioblastoma (GBM) most commonly appears to be intraparenchymal tumor, and intraventricular GBMs are rarely reported. In previous reports, the sites of origin were not identified. Here, we report a rare case of intraventricular mucin-producing GBM in a 73-year-old woman who had a strongly enhancing tumor in the right anterior horn of the lateral ventricle. The tumor had previously been identified one and a half years ago as a small asymptomatic lesion attached to the septum pellucidum. It had been documented to gradually enlarge during subsequent follow-up examinations. The patient underwent a gross total resection of the tumor, and a soft and gelatinous mass was observed. The pathological diagnosis was compatible with GBM, and numerous tumor cells having cytoplasmic mucin vacuoles were observed. Genetic analysis revealed TP53 and NFKBIA deletions. The patient received postoperative concurrent chemotherapy with temozolomide and radiotherapy, followed by maintenance administration of temozolomide. A follow-up examination seven months later detected an asymptomatic local recurrent lesion, which was treated with gamma-knife therapy, followed by bevacizumab administration for six months. The patient has remained clinically well for five years following surgery. The origin of a rare tumor entity, intraventricular GBM, and the specific spatial and pathological findings in our case are discussed in this report.
- Open Access
- 30 July 2021
- Published by SAGE Publications in Acta Radiologica Open
- Vol. 10 (7)
Papillary craniopharyngioma coexisting with an intratumoral abscess in a pediatric patient: A case report and review of the literature
Craniopharyngiomas are benign neoplasms with two histological subtypes: adamantinomatous and papillary. Papillary craniopharyngiomas are rare in children, and those with a pituitary abscess within are even rarer. Herein, we present the case of a 14-year-old boy with a papillary craniopharyngioma and a coexisting intratumoral abscess, who was hospitalized for persistent pyrexia, polyuria, and polydipsia. The absence of calcification on computed tomography, high signal intensity inside the tumor on diffusion-weighted imaging, and clinical findings such as fever, a high inflammatory response, and meningitis, as well as short-term morphological changes on imaging, could aid in diagnosis.
- 30 July 2021
- Published by SAGE Publications in Acta Radiologica Open
- Vol. 10 (7)
Open AccessPapillary craniopharyngioma coexisting with an intratumoral abscess in a pediatric patient: A case report and review of the literature
Craniopharyngiomas are benign neoplasms with two histological subtypes: adamantinomatous and papillary. Papillary craniopharyngiomas are rare in children, and those with a pituitary abscess within are even rarer. Herein, we present the case of a 14-year-old boy with a papillary craniopharyngioma and a coexisting intratumoral abscess, who was hospitalized for persistent pyrexia, polyuria, and polydipsia. The absence of calcification on computed tomography, high signal intensity inside the tumor on diffusion-weighted imaging, and clinical findings such as fever, a high inflammatory response, and meningitis, as well as short-term morphological changes on imaging, could aid in diagnosis.
- 18 June 2021
- Published by Wiley in Pathology International
- Vol. 71 (8) , 556-558
Acute aortic dissection associated with wild‐type transthyretin amyloid
- 18 June 2021
- Published by Wiley in Pathology International
- Vol. 71 (8) , 556-558
Acute aortic dissection associated with wild‐type transthyretin amyloid